A G·U base pair in the eukaryotic selenocysteine tRNA is important for interaction with SePF, the putative selenocysteine-specific elongation factor  by Mizutani, Takaharu et al.
A GWU base pair in the eukaryotic selenocysteine tRNA is
important for interaction with SePF, the putative
selenocysteine-speci¢c elongation factor
Takaharu Mizutani*, Kazutaka Tanabe, Kenichiro Yamada
Faculty of Pharmaceutical Sciences, Nagoya City University, Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan
Received 11 April 1998
Abstract In Escherichia coli, selenocysteine biosynthesis and
incorporation into selenoproteins requires the action of four gene
products, including the specialized selenocysteine tRNASec and
elongation factor SELB, different from the universal EF-Tu. In
this regard, the situation is less clear in eukaryotes, but we
previously reported the existence of SePF, a putative SELB
homologue. The secondary structure of the tRNASec differs
slightly in eukaryotes, due to a change in the lengths of several
stems. Two non-Watson-Crick base pairs, G5aWU67b and
U6WU67, reside in the acceptor stem and are conserved in the
course of evolution. Since it has already been reported that
changing them to Watson-Crick base pairs did not affect the
serylation or selenylation levels of tRNASec, we asked whether
these non-Watson-Crick base pairs are required for the
interaction with SePF. To this end, tRNASec variants carrying
Watson-Crick changes at these positions were tested for their
ability to maintain the interaction with SePF. In these assays, the
tRNASec-SePF interaction was determined by the protective
action it confers against hydrolysis of the amino acid ester bond,
under basic conditions. All the changes introduced at U6WU67 did
not significantly affect the interaction. Interestingly, however,
the G5aWU67b to G5a-C67b substitution was sufficient, by itself,
to lead to unprotection of the ester bond. Therefore, our finding
strongly suggests that SePF is unable to interact with a tRNASec
mutant version carrying a Watson-Crick G5a-C67b instead of
the wild-type G5aWU67b base pair, establishing that G5aWU67b
constitutes a structural determinant for SePF interaction.
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1. Introduction
Selenium is an essential trace element. This was proved by
its administration to patients su¡ering from Keshan disease,
endemic in the Keshan area in China [1]. Selenium is mainly
found as selenocysteine (Sec), its major biological form. This
amino acid resides in the catalytic centers of selenoenzymes
involved in oxidation-reduction reactions, such as glutathione
peroxidase [2] and type I iodothyronine 5P deiodinase [3]. Bio-
synthesis and co-translational incorporation of this amino
acid into selenoproteins requires four gene products in bacte-
ria [4]. Brie£y, a specialized tRNA, tRNASec, is charged with
serine by the conventional seryl-tRNA synthetase (SerRS).
The seryl residue is converted to a selenocysteyl residue on
the tRNA, by the enzyme selenocysteine synthase which uti-
lizes a phosphoselenoate moiety, provided by the selenophos-
phate synthetase. Since selenocysteine is encoded by UGA [5],
otherwise used as a stop codon, a mechanism allows discrim-
ination between stop and selenocysteine codons. Two actors
participate in this mechanism: a stem-loop structure in sele-
noprotein mRNAs, lying immediately 3P to the UGA codon,
and SELB, a speci¢c translation factor acting in place of the
classical EF-Tu. SELB binds both the tRNASec and the
mRNA stem-loop, thereby bringing the Sec-tRNASec to the
A site of the ribosome.
Much less is known about the eukaryotic machinery and
not all the participants have been identi¢ed yet. cDNAs for
selenophosphate synthetases were isolated, and it was intrigu-
ing to discover that one form of this enzyme also contains
selenocysteine [6]. We characterized biochemical fractions of
selenocysteine synthase in the cytosol of bovine and murine
liver [7,8]. It looks as if this enzyme is constituted by di¡erent
types of subunits, in contrast to the bacterial counterpart [4].
This mammalian Sec synthase reaction proceeds like the con-
certed mechanisms of subunits of Glu-tRNAGln amidotrans-
ferase in Bacillus subtilis [9]. In an earlier work we found, in
bovine liver microsomes, a 50 kDa protein that carries a pro-
tective activity against hydrolysis of the aminoacyl-tRNA es-
ter bond [10,11]. We called this factor SePF (for selenocysteyl-
tRNA protecting factor) and showed that it also has the prop-
erty of bringing the selenocysteyl-tRNASec to a UGA codon
on microsomes. SePF therefore represents the best candidate
for being the eukaryotic-SELB homologue.
Structure-function studies in tRNASec established that the
long acceptor and D-stems of this tRNA constitute structural
determinants for selenocysteine synthase recognition [12^14].
In the course of this work, it was found that two non-Watson-
Crick base pairs, G5aWU67b and U6WU67, which are rather
well conserved in the course of evolution, are not essential
for the serylation step, nor for the seryl to selenocysteyl con-
version step. In this work, we asked whether they could be
implicated in the interaction with SePF and found that the
universal wobble G5aWU67b base pair, by itself, is important
for the SePF protecting activity.
2. Materials and methods
2.1. tRNA constructs and in vitro transcription by T7 polymerase
Synthetic bovine wild-type and mutant Sec tRNAs were constructed
by hybridizing six couples of 14^24mer oligonucleotides containing
the desired sequences as described in [12]. In these constructs, the
promoter of the T7 RNA polymerase is included immediately 5P of
the coding sequence. The sequences of the oligo couples, which were
used to synthesize the wild-type tRNASec, are given in Fig. 1.
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Conditions for transcription in vitro with T7 RNA polymerase were
as described in [12]. The RNA products were puri¢ed by gel electro-
phoresis and electroeluted.
2.2. Selenocysteylation of tRNASec
Prior to use, tRNA transcripts were renatured by heating to 65‡C
for 3 min and then at 25‡C for 5 min. tRNASec (0.02 nmol) in 20 Wl of
0.2 M HEPES-Na (pH 7.4), 20 mM MgCl2, 20 mM KCl, 20 mM
mercaptoethanol, 0.4 mM serine, 10 mM ATP, and 5 Wg SerRS were
mixed with 10 Wl of [75Se]HSe3 (2 Ci/mmol), 10 Wl of selenocysteine
synthase and 10 Wl of a selenide-activating protein and incubated at
30‡C for 2 h [7]. [75Se]Sec-tRNA was collected by ethanol precipita-
tion, after the addition of 1 Wl glacial acetic acid to protect the Sec-
tRNASec ester bond. This precipitate contained [75Se]HSe3 and en-
zymes. In order to remove these contaminants, some treatments were
performed as follows [10,11]. In the treatment with bu¡ered phenol,
the crude [75Se]Sec-tRNA precipitate was dissolved in 40 Wl of distilled
water and the equivalent volume of bu¡ered phenol was added. After
mixing vigorously for 5 min, the tube centrifuged for 5 min at
2000Ug. The upper layer was recovered carefully. Then the
[75Se]Sec-tRNA was reprecipitated with ethanol just as in the other
treatments. In order to measure the amount of [75Se]Sec-tRNASec, the
recovered [75Se]Sec-tRNA was hydrolyzed with a small volume of
2.5% NH4OH for 30 min at 37‡C and the tRNA reprecipitated with
ethanol. The supernatant which contained the hydrolyzed [75Se]Sec
arising from Sec-tRNASec was immediately analyzed by TLC on a
silica gel G plate developed with n-butanol/acetic acid/water (4:1:1).
After development, the [75Se]Sec was detected with a BioImage Ana-
lyzer BAS2500. Thus, contaminants, such as [75Se]HSe3, were re-
moved from the above crude [75Se]Sec-tRNA precipitate with bu¡ered
phenol. This puri¢ed Sec-tRNA was used for assaying for the SePF
protecting activity against alkaline hydrolysis of the Sec-tRNASec es-
ter bond.
2.3. Assay of [75Se]Sec-tRNA protecting activity against alkaline
hydrolysis (SePF assay)
The standard assay mixture (¢nal volume of 50 Wl) contained 50
mM Tris-HCl (pH 7.5), 75 mM KCl, 0.2 mM DTT, 0.1 mM unhy-
drolyzable GTP analogue (GMP-P(CH2)P), 5 Wg BSA, [75Se]Sec-
tRNA and an appropriate amount of SePF [10]. Incubation was car-
ried out for 10 min at 30‡C. Generally, aminoacyl-tRNAs were labile
and easily hydrolyzed under these conditions (pH 7.5 for 30 min).
Alkaline hydrolysis was terminated by ethanol precipitation, and the
free [75Se]Sec liberated from tRNA was removed from by centrifuga-
tion. [75Se]Sec-tRNA protected in the precipitate was hydrolyzed in
2 N ammonia for 60 min at 30‡C. The solution was mixed with
2 volumes of ethanol and the mixture was re-centrifuged. The super-
natant was immediately analyzed by TLC on silica-gel G. After devel-
opment, [75Se]Sec on the silica plate was detected and measured with a
BioImage Analyzer. Authentic selenocysteine, used as a marker, was
co-chromatographed and colored by the ninhydrin reaction.
2.4. Chromatography condition
The post-mitochondrial supernatants of bovine liver extracts were
centrifuged at 150 000Ug. The precipitates and the supernatants at
150 000Ug were used as microsomes and cytosol (S-100), respectively.
Microsomal proteins were extracted with 1 M NH4Cl from bovine
liver microsomes, collected at 150 000Ug. CM-Sephadex C-25 column
(3U30 cm) chromatography was performed with a standard bu¡er
containing 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 10 mM 2-mer-
captoethanol and 10% (v/v) glycerol [10]. The elution was performed
with a 0^0.8 M KCl. The volume of each fraction was 10 ml. All the
steps were carried out in a cold room at 4‡C.
3. Results
The secondary structure of eukaryotic tRNASec shows some
variation with respect to classical tRNAs [15]. In particular,
the AA- and D-stems are longer, containing 9 and 6 base
pairs, respectively. In addition to this length, the acceptor
stem contains the two non-Watson-Crick base pairs
G5aWU67b and U6WU67 (Fig. 1). The latter is conserved in
vertebrates, but also in Drosophila melanogaster and Caeno-
rhabditis elegans [16]. The wobble G5aWU67b base pair is con-
served in vertebrates, C. elegans and the archaeon Methano-
coccus jannaschii [17]. Surprisingly, an A65aWG67b base pair is
found at the same location in Drosophila. This strongly sug-
gests that, even though a wobble base pair per se is not strictly
required, the structure and/or function of the tRNASec neces-
sitates the occurrence of a non-Watson-Crick base pair at this
position. In an earlier work, it was shown that neither the
G5aWU67b nor the U6WU67 base pairs are crucial to the ser-
ylation and selenylation steps [12]. This ¢nding raised the
possibility that one or the other base pair might be required
for further steps in the decoding of the selenocysteine codon.
In this regard we found, after biochemical fractionation of
microsomal extracts, a protein activity that has the ability
to protect the ester bond of the Sec-tRNASec, under basic
conditions [10]. This activity, which we called SePF, is di¡er-
ent from the elongation factor eEF-1K and may well be the
eukaryotic homologue of the prokaryotic selenocysteine-spe-
ci¢c elongation factor SELB. Therefore, we set out to deter-
mine whether the non-Watson-Crick base pairs are necessary
for interaction with the SePF.
In preliminary experiments, we wished to know whether
SePF could also be detected in cytosol from bovine liver.
When extracted from bovine liver microsomes at 1 M NH4Cl,
SePF activity elutes at 0.25 M KCl on CM-Sephadex chro-
matography as shown in the lower panel of Fig. 2. A similar
elution pro¢le could be obtained, starting from the cytosol
fraction, as shown in the upper part of Fig. 2, in which the
SePF activity was eluted at 0.25 M KCl. Thus, the SePF
activity was found in both S-100 and microsomal fractions.
As the next step, we measured the activity content in the
fraction of SePF activity (fraction 26) in Fig. 2 by the dose-
dependent manner as shown in Fig. 3A. Fig. 3B shows the
results of dot-blot analyses of Sec. The activity of SePF in
cytosol was weak at 2 Wl and 5 Wl, and was clearly found at 10
Wl. Meanwhile, the SepF activity of the microsomal fraction
was found at 2 Wl and saturated at 2 Wl. The fractions applied
on the column of CM-Sephadex were obtained from the same
bovine liver preparation. From Fig. 3, it can be concluded
that microsomal fractions contained about 10 times as much
SePF activity as those from cytosol. This result is interesting,
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Fig. 1. The acceptor stem of the vertebrate selenocysteine tRNA
with the mutant constructs used in this study. G5aWU67b was re-
placed by either of the two base pairs mentioned on the left, and
U6WU67 by one of the four base pairs on the right.
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because this distribution of SePF is di¡erent from that of
eEF-1K, much of which is contained in the cytosol. Almost
all translational components, such as tRNAs and aminoacyl-
tRNA synthetase, are contained as a compartment around
ribosomes [18] and it is plausible that SePF is also associated
with ribosomes.
The mutants tRNAsSec carrying the base pair substitutions
in the acceptor stem, shown in Fig. 1, were prepared by in
vitro transcription with T7 RNA polymerase. Four mutants
were designed to change U6WU67 to U-A and G-C Watson-
Crick base pairs on the one hand, and to UWG and GWU wob-
ble base pairs, on the other. The wobble G5aWU67b was sub-
stituted to an Watson-Crick G-C and a non-Watson-Crick
AWG base pair. These tRNASec mutants were subsequently
selenylated in vitro and the protection capabilities of SePF
toward the corresponding [75Se]Sec-tRNASec ester bonds
were assayed. The typical patterns after protection reaction
are shown in Fig. 4. In Fig. 4, we found that the spot density
of [75Se]Sec of T27 was weak, compared to the spots of the
wild-type. This indicates that the mutation from G5aWU67b to
G-C (T27) was not protected by SePF. The density of T25
(the mutation from U6WU67 to G-C) and T28 (from G5aWU67b
to AWG) was clear and this indicated that these two mutants
were protected and recognized by SePF. Table 1 shows that
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Fig. 3. Dose-response relationships of SePF activity in both frac-
tions 26 in Fig. 2. The upper part shows the relationship between
dose and SePF activity. Circles indicate fraction 26 from chroma-
tography of microsomal extracts and triangles indicate fraction 26
from cytosol in Fig. 2. The abscissa gives the dose indicated by vol-
ume of both fractions 26 in Fig. 2. The bottom part represents the
results of a radio-image pattern. No is non-treated wild-type
[75Se]Sec-tRNA and original substrate for SePF assay.
Table 1
Summary of the activity of tRNA mutants recognized by SePF
tRNA Activitya
Wild-type ++
T11 A8CU +
T13 U6WU67CU-A ++
T14 U6WU67CUWG ++
T23 U6WU67CGWU ++
T25 U6WU67CG-C ++
T27 G5aWU67bCG-C 3
T28 G5aWU67bCAWG ++
aThe symbol ++ indicates a value of 70% or more of wild-type
tRNASec and 3 is a value of 30% or less. + is the middle value.
Fig. 2. Elution patterns of cytosol (A, upper panel) and microsomal
extracts (B, lower panel) on CM-Sephadex chromatography. The
thick lines indicate the absorbance at 280 nm and the circles the
SePF activity in 10 ml fractions. The KCl gradient is indicated.
Fig. 4. Dot-blotted patterns (in duplicate) of [75Se]Sec-tRNA wild-
type and mutants after the assay of Sec-tRNA protecting activity.
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none of the mutations engineered at U6WU67 a¡ected the SePF
activity in a signi¢cant manner.
This peculiar U6WU67 pair did not function to SePF, as well
as serylation and selenocysteylation [12]. The substitution at
G5aWU67b was more interesting since conversion to a G-C
Watson-Crick base pair was su⁄cient to completely inhibit
the SePF activity. This ¢nding strongly suggests that the
SePF is unable to interaction with a tRNASec mutant version
carrying a G-C base pair, which may constitute one determi-
nant for SePF recognition. In contrast, the substitution to
AWG (T28), another type of non-Watson-Crick base pair, did
not lead to abolition of this activity. From these experiments,
we conclude that a tRNASec mutant carrying G5a-C67b in-
stead of G5aWU67b is deleterious to the SePF activity, suggest-
ing a functional role of G5aWU67b, but not U6WU67, for the
interaction with this protein.
4. Discussion
We have examined in this work the putative function of two
non-Watson-Crick base pairs, G5aWU67b and U6WU67, resid-
ing in the long AA-stem of mammalian tRNASec [15]. The
interest that prompted us to focus our attention on these
base pairs arose from phylogenetic considerations: U6WU67
is invariant in vertebrates, Drosophila and C. elegans [16] ;
G5aWU67b is conserved in vertebrates and C. elegans, but in
Drosophila this wobble base pair is replaced by A5aWG67b [16],
another non-Watson-Crick base pair, suggesting that a non-
Watson-Crick status is required for some reason. In fact, an
earlier work showed that neither the serylation nor selenyla-
tion steps were particularly a¡ected by Watson-Crick replace-
ments at these positions [12]. Instead, we have shown here
that the protective activity provided by SePF, the putative
selenocysteine elongation factor, against hydrolysis of the
Sec-tRNASec ester bond is dramatically a¡ected by a G5a-
C67b conversion. This ¢nding strongly suggests that this
GWU base pair is a structural determinant for recognition or
binding of SePF to the tRNASec. This is not unprecedented
and the G3WU70 base pair in tRNAAla is one important deter-
minant for recognition by the cognate aminoacyl-tRNA syn-
thetase [19]. Several other examples have been described in the
literature to involve GWU pairs as unique determinants for
RNA-RNA or RNA-protein recognition [20]. There are three
GWU base pairs in tRNASec. The ¢rst is G5aWU67b, which has
a role in the interaction with SePF, and the second is
U12WG23, which should have a role in the interaction with
selenocysteine synthase in a base-speci¢c manner [14],
although this interaction is not indispensable but increases
the a⁄nity with selenocysteine synthase. This second
U12WG23 base pair is well conserved between tRNASec of E.
coli and mammalia. The third is G27WU43, whose function is
not clear but it may have a role in the maintenance of the
active structure of tRNASec.
The other result of this study shows that a GWU to AWG
substitution does not a¡ect protection by SePF. This is per-
fectly consistent with the fact that the Drosophila tRNASec
possesses an AWG pair at this position. However, this poses
the question as to why a G-C pair is deleterious while an AWG
is not. In a GWU pair, the exocyclic amino group of the gua-
nine projects into the minor groove of the RNA helix, thus
providing a functional group available for ligand recognition.
This group is not longer available in the Watson-Crick G-C
pair, since it is hydrogen bonded to the O2 of the cytosine. An
AWG pair, whatever the geometry, is not isosteric to the GWU
pair and will not provide a free NH2 group. One possibility is
that the sole presence of a non-Watson-Crick base pair, GWU
or AWG, provokes a structural modi¢cation of the phospho-
diester backbone of the RNA helix, su⁄cient to provide a
recognition signal for SePF. In any event, it is worth noting
that the tRNASec of the archaeon M. jannaschii, despite a
great overall sequence divergence with the eukaryotic homo-
logue, also possesses a GWU base pair at this position [17]. This
base pair is therefore universal and, taking into account the
fact that archaea appear to possess a selenocysteine machinery
resembling that in eukaryotes [21], must play a key role in this
process.
Meanwhile, recently, the translation machinery on ribo-
somes has been clari¢ed. EF-Tu in E. coli recognized the
helical AA-stem and CCA terminal having aminoacyl residues
and 5P-terminal and T-stem by all three domains in its EF-Tu
[22,23]. The recognition of the AA strand and T-stem by EF-
Tu was also manifested by the study with minihelix RNA [24].
The recognition site on EF-Tu was analyzed by X-ray [25] and
A, P, and E sites on ribosomes have also been shown by
electron cryomicroscopy [26]. The pattern of a complex of
EF-Tu-aa-tRNA binding on ribosomes has also been shown
[27]. Meanwhile, it has been reported that EF-G takes a struc-
ture mimicking that of tRNA [22]. This molecular mimicry
becomes the general rule, because RF recognizing stop codon
also takes a tRNA-like structure [28].
In E. coli, there is an elongation factor (SELB) speci¢c to
Sec-tRNA, except EF-Tu which does not recognize Sec-
tRNA. The N-terminal of SELB in E. coli recognizes Sec-
tRNASec. The C-terminal half of SELB recognizes a stem-
loop structure downstream of the Sec UGA codon. This
stem-loop structure has a role of discrimination between the
Sec UGA codon and the stop UGA codon [4]. Sec UGA
codon embedding in this stem-loop structure may be pro-
tected from attack of RF. Similar stem-loop structures were
found on 5P UTR and 3P UTR separating from Sec UGA
codon in some bacterial systems [21]. The molecular mass of
SELB is 80 kDa, larger than that of EF-Tu, which is 45 kDa.
This di¡erent region has the function to interact with this
stem-loop structure. EF-Tu could not recognize 13 bp of
AA-stem and T-stem of Sec-tRNASec [29]. But, there is a
discrepant result of EF-Tu recognizing the minihelix having
13 bp [24]. It has been reported that the hinge region between
AA- and T-stems on tRNASec of E. coli is anti-determinant to
EF-Tu [30]. EF-Tu also did not recognize the AA-stem of
initiator tRNA which has a non-base pair at position 1^72
[31].
A Sec-tRNA-protein-antibody complex was found in sera
from patients with autoimmune chronic active hepatitis [32].
It is possible that the protein of 50 kDa in the complex is our
SePF because of its consistency of molecular mass and not
SerRS of molecular mass 65 kDa. We suppose that this phe-
nomenon depends on the increase of Sec-tRNA by some
pathogenic condition such as in£ammation. We showed that
the level of Sec-tRNASec was increased three times in dystro-
phic muscle of in£ammation as well as an increase in Se-GPx
[33]. It was considered that this increase was dependent upon
the oxidative stress in the muscle [34], because Sec-tRNA is
essential for the production of Se-GPx, which decomposes
hydroxyl peroxide in cytosol.
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